Amplio Pharma BV
PrivateLast Round
Seed
Feb 17, 2026
Est. Valuation
$9.5M
Total Funding Raised
$1.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Amplio Pharma BV operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Seed round in February 2026.
Amplio Pharma BV is a pharmaceutical company developing improved versions of existing drugs intended to treat autoimmune diseases like rheumatoid arthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplio Pharma BV Comparables
Compare Amplio Pharma BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MAA Laboratories | 73% | |
| Elevara Medicines | 72% | |
| Halozyme Therapeutics | 67% |
For institutional investors. Book with your work email.
Amplio Pharma BV Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amplio Pharma BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROM InWest | Seed |
| Innovatiefonds Noord-Holland | Seed |
| Libertatis Ergo Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 105% MoM.
- Feb 17, 2026
$1.4M round led by Libertatis Ergo Holding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 7, 2026
Amplio Pharma is launching an $11.2M Series A financing to fund a phase IIa proof-of-concept trial in the Netherlands for NovoBioJect.
- receives_financingOct 2, 2026
Amplio Pharma received $1.57M in Seed financing backed by Libertatis Ergo Holding, Amsterdam UMC Ventures Holding, ROM InWest and Innovatiefonds Noord-Holland.
For institutional investors. Book with your work email.
Amplio Pharma BV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amplio Pharma BV's valuation, stock price, and market status.
Is Amplio Pharma BV a public or private company?
Amplio Pharma BV is a private company.
What is the current stock price of Amplio Pharma BV?
Amplio Pharma BV is a private company, so its shares have no public market price. Caplight tracks Amplio Pharma BV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amplio Pharma BV worth (valuation)?
Amplio Pharma BV's valuation is estimated at $9.5M based on funding round data.
Can I buy Amplio Pharma BV stock?
Amplio Pharma BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amplio Pharma BV's last funding round?
Amplio Pharma BV's most recent funding round was Seed on February 17, 2026.
Who are the main investors in Amplio Pharma BV?
Key investors in Amplio Pharma BV include Libertatis Ergo Holding.
Will Amplio Pharma BV IPO soon?
No public IPO plans have been announced for Amplio Pharma BV.
How can I track Amplio Pharma BV secondary market activity?
Caplight tracks bids, offers, and trades in Amplio Pharma BV's shares on secondary markets.